Mersana Therapeutics, Inc. MRSN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

34/100

1/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Mersana Therapeutics, Inc. (MRSN), dont 9 achats et 40 ventes. Le total des achats d'initiés s'élève à $173.31K et le total des ventes d'initiés à $76.79K.

Les initiés notables ayant une activité récente comprennent Mott David M, Hege Kristen, Dere Willard H. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — MRSN

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2025-06-12	Mott David M	Director	Attribution de RSU	61,500	$0.36	$22.14K	61,500
2025-06-12	Hege Kristen	Director	Attribution de RSU	61,500	$0.36	$22.14K	61,500
2025-06-12	Dere Willard H	Director	Attribution de RSU	61,500	$0.36	$22.14K	61,500
2025-06-12	Protopapas Anna	Director	Attribution de RSU	61,500	$0.36	$22.14K	61,500
2025-06-12	Alleva Lawrence M	Director	Attribution de RSU	61,500	$0.36	$22.14K	61,500
2025-06-12	Hack Andrew A. F.	Director	Attribution de RSU	61,500	$0.36	$22.14K	61,500
2025-06-12	Diaz Allene M.	Director	Attribution de RSU	61,500	$0.36	$22.14K	61,500
2025-01-16	Protopapas Anna	Director	Vente Informative	8,637	$0.58	$5.01K	168,041
2025-01-16	Carvajal Alejandra	SVP, Chief Legal Officer	Vente Informative	5,096	$0.58	$2.96K	78,296
2025-01-16	Huber Martin H. Jr.	President, CEO	Vente Informative	4,514	$0.58	$2.62K	122,875
2025-01-16	Lowinger Timothy B	SVP, Chief Sci.&tech. Officer	Vente Informative	8,048	$0.58	$4.67K	257,673
2025-01-16	Deschuytner Brian	SVP, COO & CFO	Vente Informative	8,470	$0.58	$4.91K	121,393
2025-01-16	Mandelia Ashish	VP, Chief Accounting Officer	Vente Informative	3,554	$0.58	$2.06K	57,519
2025-01-16	Bala Mohan	SVP, Chief Development Officer	Vente Informative	5,939	$0.58	$3.44K	68,872
2025-01-15	Protopapas Anna	Director	Vente Informative	6,191	$0.63	$3.9K	155,428
2025-01-15	Carvajal Alejandra	SVP, Chief Legal Officer	Vente Informative	952	$0.63	$599.76	70,892
2025-01-15	Lowinger Timothy B	SVP, Chief Sci.&tech. Officer	Vente Informative	1,794	$0.63	$1.13K	245,930
2025-01-15	Deschuytner Brian	SVP, COO & CFO	Vente Informative	2,331	$0.63	$1.47K	109,030
2025-01-15	Mandelia Ashish	VP, Chief Accounting Officer	Vente Informative	1,791	$0.63	$1.13K	52,388
2025-01-15	Protopapas Anna	Director	Exercice d'Options (Vente)	21,250	-	-	-
2025-01-15	Carvajal Alejandra	SVP, Chief Legal Officer	Exercice d'Options (Vente)	12,500	-	-	37,500
2025-01-15	Huber Martin H. Jr.	President, CEO	Exercice d'Options (Vente)	11,062	-	-	33,188
2025-01-15	Lowinger Timothy B	SVP, Chief Sci.&tech. Officer	Exercice d'Options (Vente)	7,291	-	-	-
2025-01-15	Deschuytner Brian	SVP, COO & CFO	Exercice d'Options (Vente)	6,250	-	-	-
2025-01-15	Mandelia Ashish	VP, Chief Accounting Officer	Exercice d'Options (Vente)	4,519	-	-	-
2025-01-15	Bala Mohan	SVP, Chief Development Officer	Exercice d'Options (Vente)	14,583	-	-	43,750
2025-01-14	Protopapas Anna	Director	Vente Informative	11,534	$0.66	$7.61K	144,869
2025-01-14	Carvajal Alejandra	SVP, Chief Legal Officer	Vente Informative	3,330	$0.66	$2.2K	69,344
2025-01-14	Lowinger Timothy B	SVP, Chief Sci.&tech. Officer	Vente Informative	3,483	$0.66	$2.3K	242,932
2025-01-14	Deschuytner Brian	SVP, COO & CFO	Vente Informative	3,713	$0.66	$2.45K	105,111
2025-01-14	Mandelia Ashish	VP, Chief Accounting Officer	Vente Informative	1,007	$0.66	$664.62	49,396
2025-01-14	Bala Mohan	SVP, Chief Development Officer	Vente Informative	3,253	$0.66	$2.15K	60,228
2025-01-14	Protopapas Anna	Director	Exercice d'Options (Vente)	16,750	-	-	16,750
2025-01-14	Carvajal Alejandra	SVP, Chief Legal Officer	Exercice d'Options (Vente)	2,500	-	-	2,500
2025-01-14	Lowinger Timothy B	SVP, Chief Sci.&tech. Officer	Exercice d'Options (Vente)	4,792	-	-	4,791
2025-01-14	Deschuytner Brian	SVP, COO & CFO	Exercice d'Options (Vente)	6,250	-	-	6,250
2025-01-14	Mandelia Ashish	VP, Chief Accounting Officer	Exercice d'Options (Vente)	4,783	-	-	4,783
2025-01-13	Protopapas Anna	Director	Exercice d'Options (Vente)	31,250	-	-	62,500
2025-01-13	Carvajal Alejandra	SVP, Chief Legal Officer	Exercice d'Options (Vente)	8,958	-	-	17,917
2025-01-13	Lowinger Timothy B	SVP, Chief Sci.&tech. Officer	Exercice d'Options (Vente)	9,375	-	-	18,750
2025-01-13	Deschuytner Brian	SVP, COO & CFO	Exercice d'Options (Vente)	10,000	-	-	20,000
2025-01-13	Mandelia Ashish	VP, Chief Accounting Officer	Exercice d'Options (Vente)	2,646	-	-	5,292
2025-01-13	Bala Mohan	SVP, Chief Development Officer	Exercice d'Options (Vente)	8,750	-	-	17,500
2025-01-02	Alleva Lawrence M	Director	Attribution de RSU	12,521	$1.40	$17.53K	12,521
2024-12-20	Nextech Crossover I Scsp	10 Percent Owner	Inconnu	-	-	-	12,067,246
2024-12-19	Ecor1 Capital, Llc	10 Percent Owner	Autre (Achat)	8,036,688	$0.00	$803.67	8,036,688
2024-10-28	Bala Mohan	SVP, Chief Development Officer	Vente Informative	1,884	$1.90	$3.58K	54,731
2024-10-25	Bala Mohan	SVP, Chief Development Officer	Exercice d'Options (Vente)	6,250	-	-	6,250
2024-10-03	Carvajal Alejandra	SVP, Chief Legal Officer	Vente Informative	5,598	$1.96	$10.97K	63,716
2024-10-03	Lowinger Timothy B	SVP, Chief Sci.&tech. Officer	Vente Informative	5,598	$1.96	$10.97K	235,642

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration